Skip to content

iRhythm

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2021

    Shareholder lawsuit against iRhythm

    Lawsuit filed

    A shareholder filed a federal securities lawsuit against iRhythm Technologies, alleging that the company and its former CEO misled investors about the impact of a CMS reimbursement-rate change. These are allegations in the complaint.

    Source excerpt

    • On Monday a shareholder filed suit in the Northern District of California against iRhythm Technologies, Inc. (iRhythm) for federal securities violations
    • The plaintiff, on behalf of a putative class of investors, accused the company and its former CEO, Kevin M. King, of misleading investors about the impact of a U.S. Centers for Medicare and Medicaid Services (CMS) reimbursement rate change.